Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07391033

The PICCOLETO XI A-PREP Study

Impact of Lesion PREParation With Modifying Balloons During Drug-coated Balloon (DCB) Angioplasty for In-stent Restenosis (ISR) - PICCOLETO XI A-PREP Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Fondazione Ricerca e Innovazione Cardiovascolare ETS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the angiographic and clinical outcomes of aggressive versus standard balloon preparation during drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR). The study will evaluate whether more aggressive lesion preparation with cutting/scoring/OPN balloons improves outcomes compared to standard preparation with semi-compliant or non-compliant balloons.

Detailed description

PICCOLETO XI A-PREP is an investigator-initiated, multicenter, international, observational study evaluating the impact of lesion preparation strategies on outcomes following drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR). In-stent restenosis remains a clinically relevant challenge despite advances in drug-eluting stent technology and contemporary percutaneous coronary intervention techniques. DCB represents a stentless therapeutic strategy for ISR treatment, with the advantage of avoiding implantation of additional metallic layers. A key determinant of clinical outcomes in ISR, particularly with DCB angioplasty, is the adequacy of lesion preparation before definitive therapy. Effective preparation facilitates optimal drug delivery, improves luminal gain, and may reduce the risk of recurrent restenosis. A large spectrum of balloon-based modalities is available for ISR lesion preparation, ranging from semi-compliant and non-compliant balloons to more aggressive tools such as scoring and cutting balloons. Although more aggressive devices may enhance plaque modification and neointimal tissue disruption, their incremental clinical benefit over standard approaches remains uncertain. Patients will be categorized into two groups based on lesion preparation strategy: * Aggressive preparation: Cutting/Wolverine balloons, scoring balloons (any brand), and/or OPN balloons * Standard preparation: Semi-compliant balloons and/or non-compliant balloons Clinical outcomes will be assessed at 1-year and longest available follow-up.

Conditions

Timeline

Start date
2026-06-01
Primary completion
2027-12-01
Completion
2028-06-01
First posted
2026-02-05
Last updated
2026-02-05

Source: ClinicalTrials.gov record NCT07391033. Inclusion in this directory is not an endorsement.